Reports
The global dialysis disposable devices market is anticipated to expand at a promising rate from 2021 to 2031. The rising number of risks linked with the usage of non-disposable dialysis devices is likely to drive dialysis disposable devices market growth during the forecast period. Dialysis disposable devices also prevent patients from infections produced by traditional dialysis devices, which is projected to contribute to market growth.
Moreover, the global dialysis disposable devices market is expected to be driven by the decreasing rate of dialysis procedures due to the use of disposable devices and a spike in the number of dialysis patients globally. As per estimates, 6.6% of the overall US population had dialysis in 2018, and this proportion is likely to climb significantly throughout the forecast period. Furthermore, a rise in healthcare expenditure and a significant increase in the elderly population is anticipated to propel the global dialysis disposable devices market.
Key players in the global dialysis disposable devices market are Baxter International Inc., AngioDynamics Inc., B. Braun Melsungen AG, Fresenius Medical Care AG and Co. KGaA, Becton Dickinson and Co., Thermo Fisher Scientific Inc., JMS Co.Ltd., Nipro Corp., Nikkiso Co. Ltd., and Trivitron Healthcare.
Market players are pursuing a number of growth and expansion initiatives to acquire a competitive advantage. Market players also monitor value chain integration with company operations at various stages of the value chain.
The surge in the patient pool due to the increasing elderly population is projected to boost the global dialysis disposable devices market during the forecast period. As per the United Nations' 2017 World Population Ageing report, the world population aged 65 and up was 727 million in 2020. This increase in the senior population raised the demand for medical treatment, ultimately increasing healthcare spending. In 2017, for example, half of the Dutch healthcare budget was spent on those over 65. Moreover, as per the Centers for Disease Control and Prevention's 2019 figures, chronic kidney disease is more common in persons aged 65 or older (38%) than in people aged 45–64 years (13%) or 18–44 years (7%). Such factors are projected to boost the global dialysis disposable devices market.
Home therapies are becoming more popular due to flexible treatment options, lower costs, and fear of ongoing coronavirus infection. COVID-19, according to numerous evidence, causes severe immune difficulties in the most critically ill people. The results also demonstrate that COVID-19 infection causes acute kidney injury (AKI). People on dialysis need to attend clinics or hospitals 2-3 times per week, where they are at risk of getting infected with a coronavirus. To control the spread of COVID-19, the necessity to diagnose, treat and monitor patients without physical interactions has skyrocketed, resulting in a higher preference for dialysis disposable devices among patients. For instance, in July 2020, the US Federal government announced an increase in Medicare reimbursement rates for dialysis disposable devices to promote home dialysis use.
The dialysis disposable devices market in North America is projected to experience significant growth during the forecast period. The United States is expected to contribute significantly to the dialysis disposable devices market in North America.
Asia Pacific dialysis disposable devices market is anticipated to expand during the forecast period. Emphasis on peritoneal dialysis devices and expanding product range for home care settings is projected to benefit the regional market. Moreover, China and Japan are expected to be major Asian markets for dialysis disposable devices. The market is expected to expand due to the rising frequency of chronic kidney disease (CKD) in these regions.
N/A